Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease (Q40630247)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1999
edit
Language Label Description Also known as
English
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
scientific article published on September 1999

    Statements

    Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease (English)
    M A Cobleigh
    C L Vogel
    D Tripathy
    N J Robert
    S Scholl
    L Fehrenbacher
    J M Wolter
    V Paton
    G Lieberman
    D J Slamon
    1 September 1999
    2639-2648

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit